Page last updated: 2024-09-02

fingolimod hydrochloride and Sandhoff Disease

fingolimod hydrochloride has been researched along with Sandhoff Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Furusawa, E; Irisa, M; Itoh, K; Kaizu, K; Kodama, T; Ogawa, Y; Oishi, K; Saito, T; Sakuraba, H; Sano, T; Togawa, T; Tsukimura, T; Yamanaka, S; Yanagi, Y	1

Other Studies

1 other study(ies) available for fingolimod hydrochloride and Sandhoff Disease

Article	Year
FcRγ-dependent immune activation initiates astrogliosis during the asymptomatic phase of Sandhoff disease model mice. Scientific reports, 2017, 01-13, Volume: 7 Topics: Animals; Astrocytes; beta-Hexosaminidase beta Chain; Cerebral Cortex; Disease Models, Animal; Fingolimod Hydrochloride; G(M2) Ganglioside; Gliosis; Heterozygote; Immunity; Immunosuppressive Agents; Mice, Inbred C57BL; Motor Activity; Phenotype; Receptors, Fc; Sandhoff Disease; Up-Regulation; Walking	2017

Article

Year

FcRγ-dependent immune activation initiates astrogliosis during the asymptomatic phase of Sandhoff disease model mice.

Scientific reports, 2017, 01-13, Volume: 7

Topics: Animals; Astrocytes; beta-Hexosaminidase beta Chain; Cerebral Cortex; Disease Models, Animal; Fingolimod Hydrochloride; G(M2) Ganglioside; Gliosis; Heterozygote; Immunity; Immunosuppressive Agents; Mice, Inbred C57BL; Motor Activity; Phenotype; Receptors, Fc; Sandhoff Disease; Up-Regulation; Walking

2017